21506VIC MEDICATION ADMINISTRATION - PowerPoint PPT Presentation

1 / 76
About This Presentation
Title:

21506VIC MEDICATION ADMINISTRATION

Description:

MEDICATION ADMINISTRATION INJECTIONS Intramuscular injection Skeletal muscle highly vascular and its capillaries contain small pores that enables substances of small ... – PowerPoint PPT presentation

Number of Views:399
Avg rating:3.0/5.0
Slides: 77
Provided by: WilliamAt4
Category:

less

Transcript and Presenter's Notes

Title: 21506VIC MEDICATION ADMINISTRATION


1
21506VICMEDICATION ADMINISTRATION
  • INJECTIONS

2
Intramuscular injection
  • Skeletal muscle highly vascular and its
    capillaries contain small pores that enables
    substances of small molecular weight to pass
    through into the bloodstream

3
Intramuscular injection
  • Several muscles of the body have considerable
    mass and are able to be injected with quantities
    of up to several millilitres of fluid, generally
    without undue discomfort

4
Intramuscular injection
  • The gluteus medius of the buttocks is the best
    muscle to use in this respect
  • The deltoid muscle has a richer blood supply so
    good for rapid absorption, but size limit should
    be no more than 1-2 ml

5
Intramuscular injection
  • Intramuscular injections are not always given for
    quick action
  • If the drug is mixed with an oil absorption is
    slower. This type of injection is known as depot

6
Intramuscular injection
  • Exercise causes an increase in skeletal muscle
    blood flow improves absorption of a drug
  • Main danger from im injection is damage to
    nerves, especially in gluteal injections
  • Pain and sterile abscess can occur with im

7
INJECTIONS
  • Parenteral administration of medications
  • Administered by injection
  • An invasive procedure
  • Performed using aseptic techniques
  • Requires certain skills
  • Has a rapid effect

8
Preventing infection during injection
  • Prevent skin contamination
  • Wash skin with soap water when soiled with
  • Dirt
  • Blood
  • Faeces
  • Drainage
  • Swab with an alcohol swab using a circular motion
    starting at the centre and moving out in a 5 cm
    radius

9
Preventing infection during injection
  • Prevent needle contamination
  • Avoid letting needle touch contaminated surface (
    edge of ampoule, hand , needle cap counter or
    table top, patients hand)
  • Swab tops of vials with an alcohol swab
  • If needle is contaminated change needle
  • If you touch your hand on the needle change
    needle

10
Preventing infection during injection
  • Prevent syringe contamination
  • Avoid touching
  • length of plunger
  • Inner part of barrel
  • Tip or nozzle of barrel

11
TYPES OF SYRINGES
  • Tuberculin
  • Marked in 0.01 (hundreds)
  • Good for preparing small amounts of solution, or
    small precise dosages
  • Insulin
  • Marked in units
  • Made in
  • 30 units
  • 50 units
  • 100 units

12
EQUIPMENT
  • Appropriate syringe
  • Luer
  • Marked in 0.1 (tenths)
  • Luer-lok
  • Marked in 0.1 (tenths)

13
Comparison of angles of insertion for
intramuscular (90degrees),subcutaneous
(45degrees) and intradermal (15degrees)
14
HYPODERMIS OR SUBCUTANEOUS LAYER
  • Functions
  • Stores lipids
  • Insulation
  • Cushioning of the body
  • Temperature regulation
  • (Van De Graff Fox, 1986)

15
SUBCUTANEOUS INJECTIONS
  • Medication injected beneath the skin into
    connective tissue or fat under dermal layer
  • Medication should not be irritating to the tissue
    can cause
  • Severe pain
  • Tissue necrosis
  • Tissue sloughing
  • Slow absorption and can provide sustained effect
  • Unusual to use syringe greater than 5ml for a sc
    or im
  • Larger volumes create discomfort

16
HYPODERMIS OR SUBCUTANEOUS LAYER
  • This is the deepest skin layer. Connects or binds
    the dermis above it to the underlying organs
  • Mainly composed of loose fibrous connective
    tissue and fat (adipose) cells
  • Interlaced with blood vessels
  • Hypodermis in females usually 8 thicker than in
    males
  • Absorption is slower as subcutaneous tissue is
    not richly supplied with blood

17
Subcutaneous (SubQ) Tissue
18
SUBCUTANEOUS INJECTION SITES
  • Deltoid
  • Abdomen
  • Thighs

19
Subcutaneous injections
  • Inspect skin for masses or tenderness
  • Site should be free from infection scars and bony
    prominences
  • Long term therapy rotate injection site
  • Only small doses of water soluble medications
    should be given

20
Subcutaneous Sites
21
Sites recommended for Subcutaneous Injections
22
Subcutaneous injections
  • Best sc injections site are the outer posterior
    aspect of the upper arms, the abdomen from below
    the costal margins to the iliac crests and the
    anterior aspects of the thigh
  • Site most recommended for heparin is the abdomen

23
Subcutaneous injections
  • The injection site should be free from lesions
  • Bony prominences
  • Large underlying muscles
  • Nerves
  • Should be given at least 2.5cm away from last
    injection

24
Subcutaneous injections
  • Thin patients may have insufficient tissue
  • Upper abdomen is the best site with this type of
    patient
  • If 5cm of tissue can be grasped needle should be
    inserted at 90 degrees
  • If 2.5cm of tissue can be grasped the needle
    should be inserted at 45 degrees

25
  • Pucker or slightly stretch skin
  • Swab ( not necessary for insulin as it may assist
    with the formation of necrotic tissue)
  • Insert needle with a firm quick approach
  • Remove needle quickly
  • Re-swab site Do not rub particularly after
    insulin administration
  • Check patient

26
Giving Subcutaneous injections in the abdomen
27
Subcutaneous Needle
  • Gauge 25
  • Length 5/8 inch

28
  • Prepare equipment
  • Check medication (follow principles )
  • Draw up medication
  • Prepare site
  • Inject needle
  • 45º angle for most SC injections
  • 90º (straight in ) for insulin

29
Infection Control
  • Hand hygiene
  • recommended between patients
  • alcohol-based waterless antiseptic can be used
  • Gloves
  • not mandatory unless
  • potential for exposure to blood or body fluids,
  • open lesions on the hands, or
  • agency policy

30
Infection Control
  • Equipment disposal
  • never detach, recap or cut a used needle
  • place in puncture-proof container
  • dispose as infectious medical waste
  • use safety needles or needle-free devices
    whenever available to reduce risk of injury

31
Intramuscular (IM) Tissue
32
Intramuscular Sites
Deltoid
Injection Site
Vastus Lateralis
Injection Site
33
Characteristics of Intramuscular sites
  • Vastus lateralis
  • Lacks major nerves and blood vessels
  • Rapid drug absorption
  • Used for volumes up to 5mls
  • Ventrogluteal
  • A deep site situated away from major nerves and
    blood vessels
  • Less chance of contamination incontinent clients
    or infants.
  • Safe site for injections up to 4mls
  • Deltoid
  • Easily accessible but muscle not well developed
    in most clients. Used for small amounts of
    medications.
  • Not used in infants or children with
    underdeveloped muscles.
  • Potential for injury to radial and ulnar nerves
    or brachial artery.
  • Not recommended for amounts more than 2mls

34
Landmark for ventrogluteal siteB. Locating IM
injection for ventrogluteal site.
35
Landmarks for vastus lateralis siteB. Giving IM
injection in vastus lateralis
36
Landmarks for Deltoid siteB. Giving IM
injection in deltoid muscle
37
Intramuscular injections
  • Provides faster medication absorption, because of
    greater vascularity of muscle
  • Less danger of tissue damage when medications
    enter deep into the muscle
  • Risk of injecting into directly into blood vessels

38
Intramuscular Sites
  • Site selection depends on
  • persons age
  • muscle development
  • Use deltoid muscle for older children, adults
    (toddlers only if adequate muscle mass)
  • Use anatomical landmarks to locate site
  • Well developed person can tolerate 3mls without
    severe discomfort

39
  • Never administer vaccines into the buttock
  • May administer large doses of immune globulin
    into buttock of older children or adults

40
Intramuscular Needle
  • Gauge 23 or sometimes 25 in very thin patients

41
Intramuscular Injection Technique
42
Z Track
  • For irritating preparations such as iron
  • Minimises irritation and staining by sealing the
    medication in muscle tissue
  • Preference site ventogluteal

43
Z Track
  • New needle should be applied after preparation of
    injection
  • Swab site
  • Pull overlying skin and subcutaneous tissue
    approx 2.5-3.5 cm to the side
  • Holding skin taut inject deep into the muscle
  • The needle remains inserted for 10 seconds to
    allow medications to disperse evenly
  • Withdraw needle and release the skin

44
Needle Recapping
  • Never Recap needles
  • Normally against hospital policy
  • Risk of needle stick injury
  • Take sharps or kidney dish with you
  • Empty sharps containers when three quarters full

45
Infection Control
  • Equipment disposal
  • never detach, recap or cut a used needle
  • place in puncture-proof container
  • dispose as infectious medical waste
  • use safety needles or needle-free devices
    whenever available to reduce risk of injury

46
Injection Pain
  • Pain is subjective and influenced by
  • persons age
  • anxiety level
  • previous healthcare experiences
  • culture
  • Pain management
  • medical (e.g., anesthetics)
  • non-medical (e.g., diversionary techniques)

47
INSULIN ADMINISTRATION
  • Choose correct syringe size
  • Check dose of insulin (s) to be administered
  • Follow drug administration protocols
  • Draw up correct dose of insulin
  • Administer to patient in appropriate site

48
INSULIN ADMINISTRATION
  • Types of insulin
  • Rapid acting
  • Short acting
  • Intermediate acting
  • Premixed insulin
  • Premixed insulin Lispro
  • Refer to accompanying chart from Lilly

49
INSULIN ADMINISTRATION
  • Mixing insulins
  • Clear - regular
  • Cloudy - isophane
  • Withdraw amount of clear from clear vial
  • If you make a mistake discard and start again

50
INSULIN ADMINISTRATION
  • Mixing insulins
  • Keep control of plunger and withdraw amount of
    cloudy from cloudy vial
  • Always draw clear insulin up first

51
INSULIN ADMINISTRATION
  • Prepare patient
  • Administer dose
  • Unless there are facility protocol reasons it is
    not necessary to swab skin before or after
    administration
  • Do not rub site after administration
  • You may press firmly on skin with a dry swab if
    fluid appears on skin

52
INSULIN PUMPS
  • Found to be successful in
  • Brittle , labile or hard to control diabetes
  • Frequent or severe hypoglycaemia
  • Pregnancy

53
INSULIN PUMPS
  • Found to be successful in
  • Elevated HbA1C
  • Gastroparesis
  • Early nephropathy, neuropathy retinopathy
  • Post renal transplant

54
INSULIN PUMPS
  • How they work
  • Basal management
  • Pump continuously delivers a basal rate of
    insulin
  • Patient can store three basal patterns

55
INSULIN PUMPS
  • How they work
  • These patterns each have up to 48 rates in order
    to match daily, weekly and monthly activities
  • Smallest dose is 0.05 units

56
INSULIN PUMPS
  • Temporary basal rate
  • Allows person to change basal rate in response to
    stress , illnesses or changes in activity ie
    attending the gym
  • Bolus management
  • Allows person to administer a bolus dose relating
    to a blood glucose reading which is calculated by
    the machine

57
INFECTION CONTROL
  • Hand hygiene
  • recommended between patients
  • alcohol-based waterless antiseptic can be used
  • Gloves
  • not mandatory unless
  • potential for exposure to blood or body fluids,
  • open lesions on the hands, or
  • agency policy

58
INFECTION CONTROL
  • Follow facility protocols if you experience a
    needle stick injury
  • All facilities have a formal reporting system
  • Risk factors
  • Contracting infectious diseases ie HIV Hep B C
  • Blood infections ie septicaemia

59
Infection Control
  • Equipment disposal
  • never detach, recap or cut a used needle
  • place in puncture-proof container
  • dispose as infectious medical waste
  • use safety needles or needle-free devices
    whenever available to reduce risk of injury

60
Injection Pain
  • Pain is subjective and influenced by
  • persons age
  • anxiety level
  • previous healthcare experiences
  • culture
  • Pain management
  • medical (e.g., anesthetics)
  • non-medical (e.g., diversionary techniques)

61
12 steps towards a painless injection
  • 1. Prepare patient with adequate information
    before procedure
  • Allows patient to understand and comply

62
12 steps towards a painless injection
  • 2. Change needle after preparation of the drug
    and before administration
  • Ensures needle is clean, sharp dry and the right
    length

63
12 steps towards a painless injection
  • 3 Make the ventro-gluteal site your first choice
    to ensure medication reaches muscle layer
  • Used in adults and children over 7 months of age
  • 4 Position your patient so the designated muscle
    group is flexed and therefore relaxed

64
12 steps towards a painless injection
  • 5. If cleaning skin before needle entry make sure
    skin is dry before injecting
  • 6. Consider using ice or freezing spray to numb
    the pain, particularly with children or
    needle-phobic patients

65
12 steps towards a painless injection
  • 7.Use the Z track technique if appropriate
  • 8. Rotate sites from one side to other or follow
    around sites
  • 9. enter skin firmly with controlled thrust,
    holding needle at 90º angle
  • (IM injection)

66
12 steps towards a painless injection
  • 10. Inject fluid steadily and slowly about 1ml
    per 10 second to allow muscle to accommodate
    fluid
  • 11. Allow 10 seconds after completion of
    injection to allow medication to diffuse and
    withdraw needle at same angle as it entered

67
12 steps towards a painless injection
  • 12.Do not massage area but be prepared to apply
    gentle pressure with a gauze swab.

68
RESPONSIBILITIES
  • Once given, a parenteral drug cannot be
    retrieved
  • All drugs should be prepared according to
    manufacturers instructions

69
RESPONSIBILITIES
  • Ensure that policy and safety processes have been
    followed
  • Right
  • Patient
  • Drug
  • Dose
  • Route
  • Time
  • Document correctly and promptly

70
RESPONSIBILITIES
  • Know common side effects of the drugs
  • Understand that other side effects may occur
  • Know if a drug has an antidote
  • Use professional judgement and ask if unsure

71
DANGEROUS DRUGS
  • Kept in locked DD cupboard
  • D2, D1, D3 RNs must check drugs
  • Patient orders checked
  • Drug, dose, route, frequency, time, date due and
    last given
  • Check Drs signature on order

72
DANGEROUS DRUGS
  • Check pts details are correct
  • Check DD against medication order
  • Check expiry date
  • Check drug order (calculation)
  • Check pts ID carefully (same name duplicate)

73
DANGEROUS DRUGS
  • Give enteral topical medications to patient Do
    not leave on locker
  • Document discrepancies
  • Schedule 8 drugs ensure drug register correctly
    filled out
  • Date, time, patient drug, nurses administering
    drug, balance of drugs remaining

74
DANGEROUS DRUGS
  • Observe patient and document in patients history
  • Note beneficial effects
  • Note, report and chart any advers effects
  • Correctly dispose of equipment
  • Needles in sharps containers follow facility
    policies

75
COMPLICATIONS
  • Infection if strict aseptic technique not
    followed
  • Sterile abscesses
  • Oedematous or paralysed tissues have limited
    ability to absorb drugs
  • Needle too short for muscle depth

76
COMPLICATIONS
  • Nerve damage ie sciatic nerve if gluteal
    injection incorrectly sited
  • Accidental intravenous injection resulting in a
    reaction
  • Embolism from composition of drug
  • Lipohypertrophy
Write a Comment
User Comments (0)
About PowerShow.com